WELL Health Technologies Corp. (WHTCF)
| Market Cap | 769.98M -3.9% |
| Revenue (ttm) | 1.07B +35.6% |
| Net Income | 2.65M |
| EPS | 0.01 |
| Shares Out | n/a |
| PE Ratio | 289.05 |
| Forward PE | 14.82 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,400 |
| Open | 2.950 |
| Previous Close | 2.952 |
| Day's Range | 2.940 - 3.050 |
| 52-Week Range | 2.440 - 3.712 |
| Beta | 1.24 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 9, 2026 |
About WELL Health Technologies
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women’s health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates prac... [Read more]
News
WELL Health Technologies Earnings Call Transcript: Q3 2026
Normalized adjusted EBITDA grew 20% as Canadian Clinics delivered 49% revenue growth and reached a CAD 100 million annualized adjusted EBITDA run rate. 2026 adjusted EBITDA guidance is unchanged, while revenue guidance was lowered to ~CAD 1.58 billion.
WELL Health Technologies Earnings release: Q3 2026
WELL Health Technologies released its Q3 2026 earnings on November 9, 2026, summarizing the period's financial results.
WELL Health Technologies Report: Q3 2026
WELL Health Technologies published a report on November 9, 2026 containing material business information for investors and shareholders.
WELL Health Technologies MD&A: Q3 2026
WELL Health Technologies filed a regulatory document on November 9, 2026 disclosing important business information.
WELL Health Technologies Slides: Q3 2026
WELL Health Technologies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 9, 2026.
WELL Health Reports Record Q3-2026 Revenue; Canadian Patient Services Adjusted EBITDA Up 82%, Reaching $100 Million Annualized Run-Rate Milestone One Quarter Ahead of Plan
WELL achieved quarterly revenue of $407.4 million in Q3-2026, an increase of 12% compared to Q3-2025, driven by strong growth in the Company's Canadian Patient Services business where quarterly revenu...
WELL Health to Announce Third Quarter 2026 Financial Results on November 9, 2026
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positive...
WELL Health and HEALWELL Announce Competition Bureau Has Concluded Its Merger Review and Issued a No Action Letter
Vancouver, British Columbia and Toronto, Ontario--(Newsfile Corp. - October 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare compan...
HEALWELL and WELL Health Announce Competition Bureau has Concluded Its Merger Review and Issued a No Action Letter
Toronto, Ontario and Vancouver, British Columbia--(Newsfile Corp. - October 28, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence ...
WELL Health Strengthens Privacy and AI Governance Leadership with Appointment of Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory
WELL appoints recognized privacy and healthcare law expert Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory, to lead enterprise privacy, AI governance and healthcare reg...
WELL Health to Present at The Cantech Investment Conference on October 8 in Toronto
WELL Presentation Time: 9:00 AM ET in Track 1. Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a ...
WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of "WSTR" on TSXV
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health...
WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement
WELLSTAR has received conditional approval from the TSX Venture Exchange as a Tier 1 issuer, subject to satisfaction of the TSXV's customary listing conditions, and is expected to commence trading on ...
WELL Health Launches WELL Research, an End-to-End Clinical Trial Platform Built on Canada's Largest Outpatient Network
WELL Research is the clinical research brand of WELL Health Technologies. WELL Research offers the unique combination of full-service contract research organization (CRO) services in early-phase trial...
WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer
WELL has appointed Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026. Ms. Sutherland brings more than 20 years of senior financial leadership experience, including CFO roles a...
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
HEALWELL's DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching ...
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to ...
WELL Health Redeems $70 Million 5.50% Convertible Debentures
WELL Health redeemed early all of its outstanding 5.50% convertible senior unsecured debentures on August 19, 2026. Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - WELL Health Techno...
WELL Health Technologies Q2 Earnings Call Highlights
WELL Health Technologies TSE: WELL reported second-quarter revenue of approximately C$404 million, up 12% from a year earlier, while adjusted EBITDA was C$48.1 million, down 3% on a reported basis. Th...
WELL Health Technologies Earnings Call Transcript: Q2 2026
Q2 2026 saw strong revenue growth, margin expansion, and early achievement of key profitability milestones, driven by acquisitions and tech enablement. Guidance for 2026 was raised, with WELLSTAR's public listing and strategic M&A supporting future growth.
WELL Health Technologies Earnings release: Q2 2026
WELL Health Technologies released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
WELL Health Technologies MD&A: Q2 2026
WELL Health Technologies filed a regulatory document on August 6, 2026 disclosing important business information.
WELL Health Technologies Report: Q2 2026
WELL Health Technologies published a report on August 6, 2026 containing material business information for investors and shareholders.
WELL Health Technologies Slides: Q2 2026
WELL Health Technologies has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
WELL Health Achieves Record Quarterly Revenue Milestone of $400 Million in Q2-2026, Driven by 32% Revenue Growth of Canadian Patient Services, and Raises 2026 Annual Guidance
WELL achieved quarterly revenues of $400.4 million in Q2-2026, an increase of 12% as compared to Q2-2025, driven by strong growth in the Company's Canadian Patient Services Business where quarterly re...